Digest Network Come funziona
Network
/
Società
Ve
Non verificato

Vertex Pharmaceuticals Incorporated

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

60 comunicati stampa

Guarda tutti i comunicati
09/03/2026
Multimedialità
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
05/03/2026
Eventi
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Vertex to Participate in Upcoming March Investor Conferences
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
05/03/2026
Eventi
Industria
Scienza
Medicina - Varie
Sanità
Biotecnologia
Farmaceutica
Salute
Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
17/02/2026
Salute
Sanità
Farmaceutica
Cardiologia
Biotecnologia
Eventi
Web e Social Network
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
12/02/2026
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Web e Social Network
Telefonia e Varie
Mercato azionario
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
20/01/2026
Scienza
Attrezzature medico-sanitarie
Salute
Medicina - Varie
Biotecnologia
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
11/01/2026
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
22/12/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Eventi
Web e Social Network
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
06/12/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Industria
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
19/11/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Eventi
Web e Social Network
Vertex to Participate in the Citi’s 2025 Global Healthcare Conference on December 3
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0